Anatomic pathology sales will rise through 2036, driven by disease diagnosis at 48.0% of the application segment in 2026. The market was valued at USD 42.7 billion in 2025 and is expected to reach USD 73.8 billion, creating an incremental opportunity of USD 28.9 billion between 2026 and 2036.